Ipilimumab vs Telmisartan
Ipilimumab vs Telmisartan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Telmisartan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Telmisartan — 24 hours.
Chemical Properties
Molecular Formula: Telmisartan — C33H30N4O2.
Molecular Weight: Telmisartan — 514.6230 g/mol.
Type: Ipilimumab — Antibody; Telmisartan — Small molecule.